Kevin J. Basile - Concepedia

Author

Kevin J. Basile

Also Known As

K J Basile, Kevin J Basile, Kevin J. Basile

Publications

718

Citations

H-Index

Concepts

All Affiliations

Kevin J. Basile is an author at Thomas Jefferson University specializing in cell biology, tumor biology, and cancer biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	314
2	Cell Biology	3	3	314
3	Immunology	2	2	78
4	Pharmacology	1	1	16
5	Cancer Cell Biology	1	1	16

Kevin J. Basile

Publications

572

Citations

H-Index

Page 1

	Year	Citations
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3 Ethan V. Abel, Kevin J. Basile, Curtis H. Kugel, Journal of Clinical Investigation Enhanced Erbb3MedicineMelanomaCancer GenomicsCancer Biology	2013	236
TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells Michele B. Weiss, Ethan V. Abel, Melanie M. Mayberry, Cancer Research	2012	151
Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells Kevin J. Basile, Ethan V. Abel, Andrew E. Aplin Oncogene Cancer ResearchCell RegulationMedicineApoptosisImmunology	2011	62
Inhibition of mutant <scp>BRAF</scp> splice variant signaling by next‐generation, selective <scp>RAF</scp> inhibitors Kevin J. Basile, Kaitlyn Le, Edward J. Hartsough, Pigment Cell & Melanoma Research	2014	50
<i>In Vivo</i> MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors Kevin J. Basile, Ethan V. Abel, Neda Dadpey, Cancer Research	2013	34
Beneficial Effects of RAF Inhibitor in Mutant BRAF Splice Variant–Expressing Melanoma Edward J. Hartsough, Kevin J. Basile, Andrew E. Aplin Molecular Cancer Research	2014	23
Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cells. Kevin J. Basile, Andrew E. Aplin PubMed ImmunologyCell DeathFda ApprovalCancer BiologyTumor Biology	2012	16

Page 1